589 related articles for article (PubMed ID: 9274632)
1. Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
Böni R; Steinert H; Huch Böni R; Von Schulthess GK; Meyer J; Dummer R; Burg G; Westera G
Br J Dermatol; 1997 Jul; 137(1):96-100. PubMed ID: 9274632
[TBL] [Abstract][Full Text] [Related]
2. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
[TBL] [Abstract][Full Text] [Related]
3. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
[TBL] [Abstract][Full Text] [Related]
4. Planar coincidence scintigraphy and PET in staging malignant melanoma.
Steinert HC; Voellmy DR; Trachsel C; Bicik I; Buck A; Huch RA; von Schulthess GK
J Nucl Med; 1998 Nov; 39(11):1892-7. PubMed ID: 9829578
[TBL] [Abstract][Full Text] [Related]
5. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
[TBL] [Abstract][Full Text] [Related]
6. Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin.
Böni R; Steinert H; Böni RA; Lichtensteiger W; Dummer R; Hartman DS; von Schulthess GK; Burg G; Westera G
Dermatology; 1996; 193(3):198-202. PubMed ID: 8944340
[TBL] [Abstract][Full Text] [Related]
7. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma staging using whole-body positron emission tomography.
Paquet P; Hustinx R; Rigo P; Piérard GE
Melanoma Res; 1998 Feb; 8(1):59-62. PubMed ID: 9508378
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnostics.
Mruck S; Baum RP; Rinne D; Hör G
Anticancer Res; 1999; 19(4A):2685-90. PubMed ID: 10470220
[TBL] [Abstract][Full Text] [Related]
11. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
12. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
13. The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma.
Acland KM; O'Doherty MJ; Russell-Jones R
J Am Acad Dermatol; 2000 Apr; 42(4):606-11. PubMed ID: 10727305
[TBL] [Abstract][Full Text] [Related]
14. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
15. [67Ga-citrate SPECT imaging of the isolated right ventricle heart metastatic malignant melanoma in a patient with chest pain].
Dolezal J; Vizd'a J; Klzo L
Vnitr Lek; 2008 Sep; 54(9):862-5. PubMed ID: 18924347
[TBL] [Abstract][Full Text] [Related]
16. Brain tumor uptake of iodo-alpha-methyl-tyrosine.
Ell PJ
J Nucl Med; 1991 Nov; 32(11):2193-4. PubMed ID: 1941158
[No Abstract] [Full Text] [Related]
17. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
[TBL] [Abstract][Full Text] [Related]
18. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
[TBL] [Abstract][Full Text] [Related]
19. Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Jager PL; Plaat BE; de Vries EG; Molenaar WM; Vaalburg W; Piers DA; Hoekstra HJ
Clin Cancer Res; 2000 Jun; 6(6):2252-9. PubMed ID: 10873075
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Henker C; Bida B; Markwardt J; Schlag P
Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
